C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
12/1993
12/08/1993	EP0572433A1 Antigen-presenting capsid with fusion ms2-coat protein
12/08/1993	EP0267204B1 Immunopotentiation
12/08/1993	CN1079225A Tnf-muteins
12/01/1993	EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
12/01/1993	EP0571602A1 Dimer of molecular variant of apolipoprotein and processes for the production thereof
12/01/1993	EP0571538A1 Structural gene of pneumococcal protein
12/01/1993	EP0329761B1 Hiv-1-related polypeptides, diagnostic systems and assay methods
11/1993
11/25/1993	WO1993023550A2 Activation of oligomerizing receptors by using fused receptor ligands
11/25/1993	WO1993023549A2 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors
11/25/1993	WO1993023544A1 Fusion protein from feline leukaemia virus gp70 as vaccine
11/25/1993	WO1993023543A1 Clostridium perfringens vaccines
11/25/1993	WO1993023542A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
11/25/1993	WO1993023540A2 Improved methods for the preparation of endotoxin-binding proteins
11/25/1993	WO1993023435A1 Antibody assay for amylin
11/25/1993	WO1993023434A2 Bpi-immunoglobulin fusion proteins
11/25/1993	WO1993023423A1 Canine coronavirus s gene and uses therefor
11/25/1993	WO1993023081A1 Methods and agents for modulating immune response, and uses thereof
11/25/1993	CA2135748A1 Methods and agents for modulating immune response, and uses thereof
11/25/1993	CA2134326A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
11/25/1993	CA2117893A1 Variant dimers for receptor activation
11/25/1993	CA2113437A1 Fusion protein from feline leukaemia virus gp70 as vaccine
11/25/1993	CA2113278A1 Antibody assay for amylin
11/23/1993	US5264372 Receptor-based screening methods for amylin agonists and antagonists
11/18/1993	EP0570357A2 Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates
11/18/1993	EP0362272B1 Method and compositions for making acsf and acsf antagonists
11/17/1993	CN1078493A Expression of neurotrophic factors with heterologous preproregions
11/17/1993	CN1078401A Immunotoxins directed against CD33 related surface antigens
11/16/1993	US5262522 Receptor for oncostatin M and leukemia inhibitory factor
11/16/1993	CA1324331C Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use
11/11/1993	WO1993022437A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/11/1993	WO1993022436A1 Lectin domain variants of selectin
11/11/1993	WO1993022343A1 Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom
11/11/1993	WO1993022342A1 Protein l and hybrid proteins thereof
11/11/1993	WO1993021769A1 Diphtheria toxin receptor-binding region
11/11/1993	WO1993018163A3 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
11/11/1993	WO1993017712A3 Conjugates formed from heat shock proteins and oligo- or polysaccharides
11/11/1993	CA2135052A1 Diphtheria toxin receptor-binding region
11/10/1993	EP0568645A1 Mixed specificity fusion proteins
11/09/1993	US5260432 Genetic engineering
11/09/1993	US5260422 MHC conjugates useful in ameliorating autoimmunity
11/09/1993	CA1324095C Recombinant ricin toxin
11/03/1993	EP0567585A1 HEPATIC GROWTH FACTOR RECEPTOR IS THE $i(MET) PROTO-ONCOGENE
11/03/1993	EP0567470A1 Pseudomonas peptide composition and method for producing the same
11/02/1993	US5258496 Precipitation and extraction of proteins
10/1993
10/28/1993	WO1993021331A2 Polysaccharide binding fusion proteins and conjugates
10/28/1993	WO1993021328A1 Polypeptides having kinase activity, their preparation and use
10/28/1993	WO1993021325A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor
10/28/1993	WO1993021320A1 Oil-body proteins as carriers of high-value peptides in plants
10/28/1993	WO1993021316A1 Mammalian melanocyte stimulating hormone receptors and uses
10/28/1993	WO1993021232A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS
10/28/1993	WO1993021223A1 Methods and reagents for diagnosis of autoantibodies
10/28/1993	WO1993020848A1 Immunotoxins directed against cd33 related surface antigens
10/28/1993	WO1993019089A3 Oxygen carrier
10/28/1993	CA2133739A1 Immunotoxins directed against c-erbb-2 (her-2/neu) related surface antigens
10/28/1993	CA2133339A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor
10/28/1993	CA2117887A1 Polysaccharide binding fusion proteins and conjugates
10/27/1993	EP0566673A1 Biosynthetic pdgf antagonists
10/27/1993	EP0566647A1 Improved humanized immunoglobulins
10/27/1993	EP0566611A1 Analogs of piscine lhrh
10/26/1993	US5256770 Oxidation resistant thrombomodulin analogs
10/26/1993	US5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
10/21/1993	CA2093735A1 Amyloid precursor-like protein and uses thereof
10/20/1993	EP0565590A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE)
10/20/1993	EP0529065A4 Receptor-based screening methods for amylin agonists and antagonists
10/19/1993	US5254672 Synthetic peptides which contain sequences from factor VIIa, and the use thereof
10/14/1993	WO1993020439A1 Compositions and methods for regulating cellular signal transducing systems
10/14/1993	WO1993020210A1 Antibodies for treatment and prevention of respiratory syncytial virus infection
10/14/1993	WO1993020202A1 Decorin fragments and methods of inhibiting cell regulatory factors
10/14/1993	WO1993020093A1 Hybrid human/porcine factor viii
10/14/1993	WO1993020076A1 Catalytic antibodies against cocaine and methods of using and producing same
10/14/1993	WO1993019777A1 Fusion proteins comprising tumor necrosis factor receptor
10/14/1993	CA2133662A1 Antibodies for treatment and prevention of respiratory syncytial virus infection
10/14/1993	CA2132859A1 Decorin fragments and methods of inhibiting cell regulatory factors
10/14/1993	CA2132624A1 Compositions and methods for regulating cellular signal transducing systems
10/13/1993	EP0564801A1 Analysis of host cell shut-off
10/13/1993	EP0564592A1 Liver enriched transcription factor
10/13/1993	EP0564532A1 Polypeptides derived from proteins of the hepatitis c virus
10/13/1993	EP0564531A1 Enrichment method for variant proteins with altered binding properties
10/06/1993	EP0563714A2 TNF-Muteins
10/06/1993	EP0563296A1 Optimization of binding proteins
10/06/1993	EP0563198A1 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS
10/06/1993	EP0563091A1 Vaccines based on hepatitis b surface antigen
10/03/1993	CA2091313A1 Tnf-muteins
09/1993
09/30/1993	WO1993019180A1 Genetically engineered antibodies
09/30/1993	WO1993019179A1 Ifn receptors recognition factors, protein sequences and methods of use thereof
09/30/1993	WO1993019176A1 Leucine zippers
09/30/1993	WO1993019094A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
09/30/1993	WO1993019089A2 Oxygen carrier
09/30/1993	WO1993016185A3 Biosynthetic binding protein for cancer marker
09/30/1993	CA2132345A1 Oxygen carrier
09/30/1993	CA2132317A1 Ifn receptors recognition factors, protein sequences and methods of use thereof
09/30/1993	CA2130173A1 Genetically engineered antibodies
09/29/1993	EP0562624A2 Stabilization of functional proteins
09/29/1993	EP0561971A1 Fusion polypeptides
09/29/1993	EP0382781B1 Composition for treating cancers characterized by over-expression of the c-fms proto-oncogene
09/29/1993	EP0305481B1 Leader sequences for the production of recombinant proteins
09/29/1993	EP0247091B1 Modular assembly of antibody genes, antibodies prepared thereby and use
09/28/1993	US5248606 Dna encoding inactive precursor and active forms of maize ribosome inactivating protein
09/27/1993	CA2091544A1 Stabilization of functional proteins
09/22/1993	EP0560947A1 Tri- and tetra-valent monospecific antigen-binding proteins

1 ... 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 ... 295